FAQ

Haemophilus Vaccines

Known as: Haemophilus Vaccines [Chemical/Ingredient], Hemophilus Vaccines, Vaccines, Hemophilus 
Vaccines or candidate vaccines containing antigenic polysaccharides from Haemophilus influenzae and designed to prevent infection. The vaccine can… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1987-2017
02419872017

Related topics

Related topics

21 relations

Broader (1)

Bacterial Vaccines

Narrower (11)

COMVAXD 53Haemophilus influenzae type b polysaccharide vaccineHaemophilus influenzae type b-polysaccharide vaccine-diphtheria toxoid conjugate
(More)
In BloodProcess of secretionadministration & dosageagonists
(More)

Related mentions per year

Related mentions per year

1943-2018
19401960198020002020
Haemophilus Vaccines
agonists
chemical synthesis
Bacterial Vaccines
standards characteristics
Process of secretion

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
CD4+ T-cell responses among adults and young children in response to Streptococcus pneumoniae and Haemophilus influenzae vaccine candidate protein antigens.
We characterized cytokine profiles of CD4(+) T-helper (h) cells in adults and young children to ascertain if responses occur to… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
2011
2011
Haemophilus influenzae vaccine candidate outer membrane protein P6 is not conserved in all strains.
An outer membrane protein of nontypeable Haemophilus influenzae (NTHi), P6, is a vaccine candidate because it has been… (More)
Is this relevant?
2007
2007
Thimerosal and vaccines--a cautionary tale.
n engl j med 357;13 www.nejm.org september 27, 2007 1278 I 1997, Frank Pallone, a U.S. congressman from New Jersey, attached a… (More)
Is this relevant?
2006
2006
Serotype and antimicrobial susceptibility patterns of isolates of Streptococcus pneumoniae causing invasive disease in The Gambia 1996-2003.
OBJECTIVES To describe the characteristics of pneumococcal isolates obtained from patients with invasive pneumococcal disease in… (More)
Is this relevant?
2005
2005
Immunogenicity and safety of a combined hepatitis A and B vaccine administered concomitantly with either a measles-mumps-rubella or a diphtheria-tetanus-acellular pertussis-inactivated poliomyelitis…
Two studies were undertaken to investigate the concomitant administration of combined hepatitis A/B vaccine with a diphtheria… (More)
Is this relevant?
2000
2000
No major association of breast-feeding, vaccinations, and childhood viral diseases with early islet autoimmunity in the German BABYDIAB Study.
OBJECTIVE Environmental factors have been suggested to play an important role in the pathogenesis of type 1 diabetes. The aim of… (More)
  • figure 1
  • figure 2
  • table 1
Is this relevant?
1997
1997
Decline of bone and joint infections attributable to haemophilus influenzae type b.
Haemophilus influenzae has been a major cause of infectious diseases in children and has been attributed as a significant cause… (More)
Is this relevant?
1994
1994
Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated…
The safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate (PRP-T) administered concurrently in… (More)
Is this relevant?
1991
1991
A controlled trial of a killed Haemophilus influenzae vaccine for prevention of acute exacerbations of chronic bronchitis.
Sixty-four patients with chronic bronchitis with a history of recurrent respiratory tract infections were admitted to a double… (More)
Is this relevant?
1989
1989
Haemophilus influenzae type b polysaccharide vaccine: an efficacy study. Haemophilus Vaccine Efficacy Study Group.
The Haemophilus influenzae type b polysaccharide vaccine was licensed for use in the United States in April 1985. Postlicensure… (More)
Is this relevant?